Inhibition of alpha-synuclein aggregation by multifunctional dopamine agonists assessed by a novel in vitro assay and an in vivo Drosophila synucleinopathy model-Reference-Cited by-同舟云学术

Inhibition of alpha-synuclein aggregation by multifunctional dopamine agonists assessed by a novel in vitro assay and an in vivo Drosophila synucleinopathy model

Published:2016-12 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Yedlapudi Deepthi,Joshi Gnanada S.,Luo Dan,Todi Sokol V.,Dutta Aloke K.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep38510.pdf

Reference57 articles.

1. Recchia, A. et al. Alpha-synuclein and Parkinson’s disease. FASEB J 18, 617–626 (2004).

2. Forno, L. S. Neuropathology of Parkinson’s disease. Journal of Neuropathology and Experimental Neurology 55, 259–272 (1996).

3. Spillantini, M. G. et al. Alpha-synuclein in Lewy bodies. Nature 388, 839–840 (1997).

4. Clayton, D. F. & George, J. M. Synucleins in synaptic plasticity and neurodegenerative disorders. J Neurosci Res 58, 120–129 (1999).

5. Cookson, M. R. Alpha-Synuclein and neuronal cell death. Mol Neurodegener 4, 9 (2009).

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulation of Alpha-Synuclein Conformational Ensemble and Aggregation Pathways by Dopamine and Related Molecules;Frontiers in Bioscience-Landmark;2023-10-26

2. D-685 Reverses Motor Deficits and Reduces Accumulation of Human α-Synuclein Protein in Two Different Parkinson’s Disease Animal Models;ACS Chemical Neuroscience;2023-02-07

3. The role of the endolysosomal pathway in α-synuclein pathogenesis in Parkinson’s disease;Frontiers in Cellular Neuroscience;2023-01-10

4. Bivalent dopamine agonists with co-operative binding and functional activities at dopamine D2 receptors, modulate aggregation and toxicity of alpha synuclein protein;Bioorganic & Medicinal Chemistry;2023-01

5. Recent advances in dopamine D ₂ receptor ligands in the treatment of neuropsychiatric disorders;Medicinal Research Reviews;2022-09-16